SCHEMBL22155752

SCHEMBL22155752

c1ccc(-c2cccc(N(c3cccc(-c4ccccc4)c3)c3cccc4ccc5c6ccccc6oc5c34)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.37
CYP1A2 P05177 5/20 0.37
CYP1B1 Q16678 4/20 0.37
CYP19A1 P11511 2/20 0.37
ALOX5 P09917 3/20 0.35
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
MAPT P10636 3/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP3A4 P08684 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
PDE5A O76074 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
ABCB1 P08183 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22155753 0.96 ALOX5 (0.36) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5
SCHEMBL22155806 0.96 ALOX5 (0.36) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5
SCHEMBL26061224 0.93 CYP1A2 (0.36) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5
SCHEMBL24657124 0.93 CYP1A2 (0.36) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5
SCHEMBL24825197 0.93 ALOX5 (0.34) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5
SCHEMBL24887006 0.93 ALOX5 (0.34) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5
SCHEMBL24656605 0.93 CYP1A2 (0.37) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5
SCHEMBL24888998 0.93 PLA2G2A (0.37) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5
SCHEMBL24826549 0.92 CYP1A2 (0.35) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5
SCHEMBL26061531 0.92 CYP1A2 (0.36) CYP1A1CYP1A2CYP1B1CYP19A1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329025-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-12 US disclosed
US-20230329025-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-12 US disclosed
WO-2023190597-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE 出光興産株式会社 2023-10-05 WO disclosed
US-11696497-B2 Organic light emitting device LG DISPLAY CO., LTD. (KR) 2023-07-04 US disclosed
US-11696497-B2 Organic light emitting device LG DISPLAY CO., LTD. (KR) 2023-07-04 US disclosed
US-20200203620-A1 ORGANIC LIGHT EMITTING DEVICE LG DISPLAY CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203620-A1 ORGANIC LIGHT EMITTING DEVICE MAP1LC3A, MAP1LC3C, MAP1LC3B CYP1A1 673/4885CYP1A2 1383/4885CYP1B1 1065/4885
US-11696497-B2 Organic light emitting device MAP1LC3A, MAP1LC3C, MAP1LC3B CYP1A1 673/4885CYP1A2 1383/4885CYP1B1 1065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.